Fentanyl Vaccine Potential ‘Game Changer’ for Opioid Epidemic 

Study Suggests New Vaccine Could Prevent Deadly Opioid from Entering the Brain

By Laurie Fickman 713-743-8454

November 14, 2022

A research team led by the University of Houston has developed a vaccine targeting the dangerous synthetic opioid fentanyl that could block its ability to enter the brain, thus eliminating the drug’s “high.” The breakthrough discovery could have major implications for the nation’s opioid epidemic by becoming a relapse prevention agent for people trying to quit using opioids. While research reveals Opioid Use Disorder (OUD) is treatable, an estimated 80% of those dependent on the drug suffer a relapse. 

The findings, published in the journal Pharmaceutics, could not be timelier or more in demand: Over 150 people die every day from overdoses of synthetic opioids including fentanyl, which is 50 times stronger than heroin and 100 times stronger than morphine. Consumption of about 2 milligrams of fentanyl (the size of two grains of rice) is likely to be fatal depending on a person’s size.  

Similar Posts

  • Biden-⁠Harris Administration Designates Fentanyl Combined with Xylazine as an Emerging Threat to the United States

    ATLANTA, GA – Today, Dr. Rahul Gupta, Director of the White House Office of National Drug Control Policy (ONDCP), has officially designated fentanyl adulterated or associated with xylazine as an emerging threat to the United States. Xylazine is a non-opioid tranquilizer approved by the Food and Drug Administration (FDA) for veterinary use but not human use….

  • Only 1 in 4 Adults Needing Opioid Use Disorder Treatment Received Medications

    Black and Latino adults less likely to receive any treatment by Shannon Firth, Washington Correspondent, MedPage Today June 27, 2024 Only about a quarter of adults who needed treatment for opioid use disorder (OUD) received recommended medications, survey data showed. In 2022, the National Survey on Drug Use and Health (NSDUH) found that 3.7% of…

  • New study highlights opioid overdose risk following release from Oregon prisons

    By Sheraz Sadiq (OPB) In Oregon, people released from prison were 10 times more likely to overdose on opioids compared to the general population, according to a new study that tracked prison release and overdose data from 2014 to 2018. The risk of overdose doubled during the first two weeks of release, and formerly incarcerated women were…

  • The FDA approves the overdose-reversing drug Narcan for over-the-counter sales

    By Joe Hernandez / NPR The overdose-reversing drug Narcan could soon be available to buy over the counter without a prescription, the Food and Drug Administration announced Wednesday. The FDA’s approval of the nasal spray Narcan — the brand name for the drug naloxone — means the medication could be more widely available across the U.S….

  • White House Challenge

    Saving Lives From Overdose America’s overdose crisis impacts all of us. Families in small towns, large cities, Tribal lands, and every community in between are affected, no matter who they are, what they look like, or how much money they make. That’s why President Biden named beating the opioid and overdose crisis a key pillar…

  • A Horrifying Drug Called ‘Tranq Dope’ Is Spreading in the US

    The animal tranquilizer xylazine, which has been linked to severe wounds and amputations, has been detected in nearly 40 states. VICE | Manisha Krishnan November 15, 2022 After two years of sobriety, Allie Gramlich began using drugs again in April. This time around, Philadelphia’s street opioid supply was infiltrated with tranq or tranq dope, a…

Leave a Reply

Your email address will not be published. Required fields are marked *